ADOPTION OF MULTI-GENE ASSAYS IN HR +, HER2-BREAST CANCER (BC) PATIENTS IN EUROPE: RESULTS OF THE MULTIDISCIPLINARY APPLICATION OF GENOMICS IN CLINICAL PRACTICE (MAGIC) SURVEY